SCHD's 17.5% YTD Run: Smart Risk Relief or the Next Crowd Trade?

SCHD's strong year put it at the center of the defensive-income trade

A 17.5% YTD ETF

SCHD has become hard to ignore, with YTD +17.50% market price and YTD +17.46% NAV through the latest reported period. That run explains why the fund is getting so much attention now-and why the simplest defense trade may already be partly spoken for.

The appeal is still straightforward. SCHD owns mature dividend payers, and those businesses can be easier to picture in a shaky market: established earnings power, more tangible cash generation, and a 3.5% yield over the last 12 months. When investors are nervous, that income cushion can make a difference.

But strong performance also changes the setup. With the fund already up sharply, the question is no longer whether SCHD offers dividend income and broad market exposure. It is whether investors are still buying risk relief, or joining a trade that many already understand.

SCHD's process: dividend quality plus broad diversification

How the strategy is built

SCHD is not trying to be fashionable. It tracks the Dow Jones U.S. Dividend 100 Index, which screens for dividend yield and five-year dividend growth rate, while also emphasizing cash flow, return on equity, and dividend growth history. In practice, that means the fund leans toward companies that have a history of paying dividends from real business performance, not just from leverage or market euphoria.

That filter matters because dividends are one way to separate durable businesses from weaker ones. SCHD applies that test across 103 Total Holdings, with $95.7B in total assets and a 0.06% expense ratio, so investors get broad exposure rather than a narrow bet on a few names.

Why the holdings support the risk-relief case

Some of SCHD's largest positions include Abbott Laboratories at 4.66%, Amgen at 4.37%, Merck at 4.36%, Coca-Cola at 4.27%, and UnitedHealth Group at 4.22%. That mix reinforces the fund's general tilt toward established consumer, healthcare, and industrial businesses.

Recent coverage also notes that SCHD has benefited from overweight positions in Energy, Industrials, and Consumer Staples sectors. That can help during periods when investors favor steadier cash generators. It also shows why sector shifts still matter: the same exposures that support the portfolio in one environment can weigh on it if conditions change.

Income is part of the cushion

SCHD's recent yield sits around the low-3% range, including 3.5% yield over the last 12 months in one recent snapshot and roughly 3.3% in another. Either way, that income stream is one reason investors keep coming back to the fund when they want passive income without leaning entirely into speculative growth.

The real debate: still useful risk relief, or a crowded defensive trade?

What bulls still have going for SCHD

Bulls can point to a durable record, not just a recent trend. SCHD has returned +24.03% over the past year, along with +13.52% annualized over three years and +8.51% annualized over five years. That does not make the fund risk-free, but it does suggest the strategy has worked across different market conditions.

If volatility rises again, that profile can still make sense. Investors do not have to believe SCHD is cheap to believe it can improve the risk profile of a portfolio that would otherwise be heavier in weaker growth names.

Why crowding deserves attention

The bear case is simpler: after a big run, part of the upside may already be behind the fund. SCHD's recent performance is strong, but it is not so far above the benchmark that the case looks hidden or obvious only to a small group.

There is also an identity tension now. Recent headlines have framed SCHD as a hedge against an AI bottleneck bust, while other coverage has questioned whether the fund is becoming more growth- and momentum-sensitive than investors assume. That makes the current debate less about whether SCHD works and more about how much of that appeal is already reflected in the price.

What to watch from here

• Whether SCHD continues to outperform on a trailing basis, or starts tracking the benchmark more closely
• Whether sector concentration supports returns or begins to limit flexibility
• Whether the fund keeps serving as a dividend-focused alternative, or becomes harder to distinguish from broader market momentum

Common-sense takeaway: SCHD does not remove risk. It changes the mix. After a 17.5% YTD run, the decision is less about finding a secret shield and more about deciding whether that trade-off still offers value at today's level.